Teva Might Sell Division

It's exploring strategic options for its animal-health business.
Author:
Publish date:

Teva Pharmaceutical Industries

(TEVA) - Get Report

is exploring strategic options for its animal-health business and might consider shedding the division.

Teva has retained Bear Stearns as its financial adviser to assist it in the review.

Shares of Israel-based Teva were down 1.6% at $47.21 Monday.

This article was written by a staff member of TheStreet.com.